Skip to main content

News Archive

News Archive - School of Medicine

Robotic Spine Surgery Program Expands at UC San Diego Health

April 15, 2019

UC San Diego Health has invested in a new robotic technology to benefit patients in need of restorative spine surgery. This technology enables minimally invasive spine surgery, the benefits of which include potential for shorter operations, less anesthesia, smaller incisions and reduced blood loss.

In Mice, Eliminating Damaged Mitochondria Alleviates Chronic Inflammatory Disease

April 11, 2019

Treatment with a choline kinase inhibitor prompts immune cells to clear away damaged mitochondria, thus reducing NLRP3 inflammasome activation and preventing inflammation

NASA Twin Study Provides a Multi-omics View of the Human Body’s Response to a Year in Space

April 11, 2019

The NASA Twins Study is the most comprehensive integrated multi-omics, molecular, physiological, and behavioral analysis of how the human body responds to space flight to date. Study results were published in the April edition of Science

Waiting with Ablated Breath: Is This the Cure for Ventricular Fibrillation?

April 4, 2019

Patients who suffer from VF live in constant fear of triggering a cardiac event, which can only be treated with an automated external defibrillator and which can become fatal in mere seconds. But a new procedure developed at UC San Diego Health is now presenting an alternative: a curative procedure.

Genome-Wide Analysis Reveals New Strategies to Target Pancreatic Cancer

April 4, 2019

An international team of scientists led by researchers at University of California San Diego School of Medicine employed an array of next-generation sequencing and gene-editing tools, such as CRISPR, to map the molecular dependencies – and thus vulnerabilities – of pancreatic cancer stem cells.

UC San Diego Health Treats 1st Cancer Patient with Stem-Cell Derived Natural Killer Cells

April 1, 2019

Moores Cancer Center at UC San Diego Health treats the first patient treated for cancer with a human-induced pluripotent stem cell (iPSC)-derived cell therapy called FT500. Dan Kaufman collaborated with Fate Therapeutics to bring the iPSC-derived natural killer cell cancer immunotherapy to patients.

Movement Toward a Poop Test for Liver Cirrhosis

March 29, 2019

In a study of people with nonalcoholic fatty liver disease and their twins and other close relatives, UC San Diego researchers were able to diagnose liver cirrhosis simply by analyzing a person’s stool microbes.

Home-Based Tools Can Help Assess Dementia Risk and Progression

March 28, 2019

Researchers at University of California San Diego School of Medicine, with colleagues elsewhere, report on a novel four-year, randomized clinical trial evaluating different home-based methods to assess cognitive function and decline in participants over the age of 75.

Sarcasm Detectors and Gene Transfers: Institute Awards Innovative Research Scholarships

March 28, 2019

Developing how the heart forms and brain works. How to analyze sarcasm computationally. Harnessing computers to develop campaign rhetoric across the spectrum. Halıcıoğlu Data Science Institute announced innovative undergraduate research scholarship projects across academic disciplines.

Balance of Two Enzymes Linked to Pancreatic Cancer Survival

March 20, 2019

UC San Diego School of Medicine research sets the stage for clinicians to potentially one day use levels of a pancreatic cancer patient’s PHLPP1 and PKC enzymes as a prognostic, and for researchers to develop new therapeutic drugs that inhibit PHLPP1 and boost PKC as a means to treat the disease.
Category navigation with Social links